CARA Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: CARA Shares Outstanding History and CARA YTD Return |
CARA Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: CARA Shares Outstanding History and CARA YTD Return |
CARA Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-18.28% CAGR Mouse over chart for data details
|
CARA Stock Price Chart |
About Cara Therapeutics Inc |
Cara Therapeutics is an early commercial-stage biopharmaceutical company focusing on a new treatment paradigm to improve the lives of patients suffering from pruritus. Co.'s KORSUVA injection is an FDA-approved treatment for moderate-to-severe pruritus associated with chronic kidney disease, in adults undergoing hemodialysis. Co. is developing an Oral KORSUVA (difelikefalin) formulation for the treatment of pruritus in patients with atopic dermatitis, and non-dialysis-dependent chronic kidney disease. Phase 2 trials of Oral KORSUVA (difelikefalin) are ongoing in primary biliary cholangitis, and in notalgia paresthetica patients with moderate-to-severe pruritus. We show 40 historical shares outstanding datapoints in our CARA shares outstanding history coverage, used to compute CARA market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing CARA market cap history over the course of time is important for investors interested in comparing CARA's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of CARA versus a peer is one thing; comparing CARA market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like CARA can fluctuate over the course of history. With this page we aim to empower investors researching CARA by allowing them to research the CARA market cap history. |
CARA Current Stock Quote |
Free CARA Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Video: The Importance of Market Cap | |
|
CARA Share Performance |
Market Cap Peers |
Cara Therapeutics (CARA) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
CARM Market Cap History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.